Your session is about to expire
← Back to Search
Mood Stabilizer
1 for Bipolar Disorder (LAMBS/LADS Trial)
Phase 4
Waitlist Available
Led By Caleb M Adler, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.
Eligible Conditions
- Bipolar Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
Depressed Patients
Group II: 1Experimental Treatment1 Intervention
Manic Patients
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lithium carbonate
FDA approved
Lithium carbonate
FDA approved
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
433 Previous Clinical Trials
636,143 Total Patients Enrolled
22 Trials studying Bipolar Disorder
1,616 Patients Enrolled for Bipolar Disorder
Caleb M Adler, MDPrincipal InvestigatorUniversity of Cincinnati
2 Previous Clinical Trials
171 Total Patients Enrolled
2 Trials studying Bipolar Disorder
171 Patients Enrolled for Bipolar Disorder
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger